Insider Transactions Reported by 26 Insiders of Ernexa Therapeutics Inc.

Symbol
ERNA, ERNAW on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Ernexa Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Charles Cherington 10%+ Owner $3,389,720 +$4,221,826 10 Feb 2026
Freebird Partners LP 10%+ Owner $1,503,337 14 Dec 2023
George P. Denny III 10%+ Owner $1,134,456 02 Dec 2022
John D. Halpern 10%+ Owner $1,118,891 02 Dec 2022
Nicholas J. Singer Director $962,330 02 Dec 2022
Roger Sidhu Chief Medical Officer $200,012 20 Sep 2022
Kevin Damour Chief Scientific Officer $159,248 28 Jun 2022
Sandra M. Gurrola Sr. VP of Finance $1,103 21 Jun 2025
Andrew C. Jackson Chief Financial Officer 03 Jun 2022
Erich Mohr Director 08 Dec 2021
Howard J. Federoff CEO & President, Director 11 Mar 2022
Erin S. Enright Director 14 Jan 2022
Jay Sial Chief Administration Officer 11 Mar 2022
Luba Greenwood Director 08 Dec 2021
Heather B. Redman Director 14 Jan 2022
Gregory Fiore Director 01 Aug 2022
Dennis Langer Director 08 Dec 2021
William A. Wexler Director 07 Feb 2025
Matthew Angel President and CEO, Director 12 Jan 2023
Elena Ratner Director 13 Jan 2025
Dorothy J. Clarke General Counsel, Director 01 Jan 2024
Peter Cicala Director 07 Feb 2025
Sanjeev Luther President & CEO, Director 07 Feb 2025
Richard W. Wagner Former director 08 Aug 2023
James Arthur Bristol Director 07 Feb 2025
BINDER BRANT Former director 08 Aug 2023

Recent Insider Transactions by Companies or Individuals for Ernexa Therapeutics Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Charles Cherington ERNA Common Stock Purchase 143.9% $2,000,000 $0.5000 4,000,000 6,779,440 10 Feb 2026 Direct
Charles Cherington ERNA Warrants to Purchase Common Stock Purchase 4,000,000 4,000,000 10 Feb 2026 Direct
Sandra M. Gurrola ERNA Common Stock Options Exercise 37.5% 30 110 21 Jun 2025 Direct
Sandra M. Gurrola ERNA Restricted Stock Units Options Exercise 30 0 21 Jun 2025 Direct
Charles Cherington ERNA Common Stock Purchase 104% $2,221,826 $0.1046 21,241,163 41,659,743 09 Jun 2025 Direct
Charles Cherington ERNA Common Stock Purchase 22.7% 3,768,397 20,401,602 02 Apr 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.